Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

U.S. Government Awards European Co. $71 Million Anthrax Vaccine Contract
Dow Jones Newswire;
Rosenberg, Daniel


The National Institute of Allergy and Infectious Diseases has awarded a contract for 3 million doses of a new kind of recombinant anthrax vaccine from Avecia, a private company based in the United Kingdom. The $71.3 million deal is to be completed by the end of 2006. Avecia was helped by Baxter Healthcare in applying for the contract, with Baxter already a vaccine supplier to the United States and well-versed in the application process. The vaccine in question is designed to provide protection against inhalation anthrax after three or fewer doses, even if administered shortly after exposure; the current vaccine requires six injections over a period of 18 months for immunity.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.